Michael Alexander Mathews

Title: Michael Alexander Mathews: Innovator in Platelet Derivative Compositions

Introduction

Michael Alexander Mathews is a notable inventor based in Arlington, VA, who has made significant contributions to the field of medical innovations. With a total of five patents to his name, Mathews has focused on developing methods and compositions that address coagulopathy, particularly in patients who have been administered anticoagulant agents.

Latest Patents

Among his latest patents are innovative compositions for treating coagulopathy. One of his notable inventions is related to platelet derivative compositions and pluralities of containers containing the same. This invention provides methods for treating coagulopathy by administering effective amounts of compositions that include platelets or freeze-dried platelet derivatives (FDPDs). These methods aim to restore hemostasis in subjects in need, showcasing the potential of platelet derivatives in medical treatments.

Career Highlights

Mathews is currently associated with Cellphire, Inc., a company that specializes in developing innovative solutions for blood-related medical challenges. His work at Cellphire has been instrumental in advancing the understanding and application of platelet derivatives in clinical settings.

Collaborations

Throughout his career, Mathews has collaborated with several professionals in the field, including Braden Carl Ishler and Stephen Edward Amos. These collaborations have contributed to the development of his innovative patents and have enhanced the research efforts at Cellphire.

Conclusion

Michael Alexander Mathews stands out as a significant figure in the realm of medical innovations, particularly in the development of platelet derivative compositions. His contributions have the potential to improve treatment options for patients with coagulopathy, marking him as an influential inventor in the medical field.